The Effect of Gait Imagery on the Muscular Activity of Lower Limbs and Lower Body Kinematics in Stroke Survivors

January 19, 2026 updated by: Hana Haltmar

The Effect of Gait Imagery on the Muscular Activity of Lower Limbs and Lower Body Kinematics in Subacute Stroke Survivors

The aim of the study is to evaluate the effect of normal gait imagery and gait on a line imagery on lower limb muscle activity and lower body kinematics in stroke survivors.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Gait imagery is a cognitive process involving the mental simulation of a gait that is not actually performed. According to current studies, gait imagery has very similar neural activity to that observed in real gait. This activity can be observed not only at the central level, but also at the end effector - the muscle - using surface electromyography. Across studies, muscle activity and kinematics are evaluated in particular when imagining analytical movements of the upper or lower limbs, but complex and posturally more demanding movements (in our case, gait and its modification - gait on a line) are studied to a lesser extent. Independent walking and the ability to adapt it to the terrain is important in rehabilitation therapy for patients with limited mobility. These individuals include, among others, a stroke survivors. The aim of the study is therefore to evaluate the effect of normal gait imagery and gait on a line imagery on lower limb muscle activity and lower body kinematics in these individuals.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Olomouc, Czechia, 77900
        • University Hospital Olomouc
      • Olomouc, Czechia, 77111
        • Palacky University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Subacute stage (1 week - 2 months after the onset of the attack) after primary attack of stroke
  • Ischemic origin of stroke
  • Good cognitive level to understand the study
  • Minimum age of 18 years
  • Clinically manifested hemiparetic gait with ability to perform independent walking for at least five minutes
  • Mild motor deficit with ability to maintain standing without any support
  • Ability to walk independently without any manual assistance of another person (≥ 3/5 points according to the Functional Ambulation Categories)
  • Good level (≥ 4/7 points) of kinesthetic and visual MI according to the Czech version of the MIQ-RS questionnaire

Exclusion Criteria:

  • Present impairments in communication and cognition
  • An additional neurological, internal, psychological or psychiatric disorder or severe musculoskeletal disorder that may affect the ambulation
  • Previous experience with MI
  • Pain during the measurement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention

All individuals will be instructed to realize normal gait imagery (NGI) and gait on the line imagery (GLI) modalities in a single experimental session. The order of imagining these two gait modalities was randomized and both modalities consisted of these tasks: rest (non-imagery task), NGI/GLI before and after the real execution of normal gait/tandem gait on the line. The order of the tasks was not randomized.

Individuals are also asked about the ease/difficulty of imagining both NGI/GLI before and after the real execution of gait tasks using a five-point scale.

Each task is measured once for 30 s with respect to sustained attention and possible onset of fatigue.

The initial position, which is identical for all measured tasks, consisted of an upright bipedal stance in front of an unobtrusive white screen with feet at pelvic width, upper limbs held loosely along the body, eyes open and facing forward. During the rest task, non-motor imagery task, participants are instructed to sing the song "Happy Birthday" in their minds.

NGI before the real execution of normal gait and GLI before the real execution of gait on the line are tasks associated with the imagery of normal gait or tandem gait on the line. Participants first observed a 5 m section of the corridor for NGI, or a line located in the middle of the same corridor for GLI.

The last tasks, NGI after the real execution of normal gait and GLI after the real execution of gait on the line, differed from above mentioned tasks in the immediate real experience of normal gait or gait on the line.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective measurement of muscle activity
Time Frame: Day 1
Muscle activity [V] will be measured by surface electromyography during all tasks (rest and gait imagery before/after real gait execution) across both gait imagery modalities (normal gait imagery and gait on the line imagery).
Day 1
Objective measurement of lower body kinematics 1
Time Frame: Day 1
Lower body kinematics will be measured by gyroscope [deg/s] during all tasks (rest and gait imagery before/after real gait execution) across both gait imagery modalities (normal gait imagery and gait on the line imagery).
Day 1
Objective measurement of lower body kinematics 2
Time Frame: Day 1
Lower body kinematics will also be measured by accelerometer [g] during all tasks (rest and gait imagery before/after real gait execution) across both gait imagery modalities (normal gait imagery and gait on the line imagery).
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire - Evaluation of gait imagery
Time Frame: Day 1
Individuals will be asked about ease/difficulty of imagining both normaI gait imagery/gait on the line imagery before and after the real execution of gait tasks using a five-point scale (maximum value - 5 points [easy] to minimum value - 1 point [difficult]).
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Haltmar H., Janura M., Haltmar M., & Elfmark M. (2024).The effect of gait imagery and its more demanding variant on muscle activity in stroke survivors. Rehabilitace a fyzikální lékařství, 31(3), 116-125. doi: 10.48095/ccrhfl2024116.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Actual)

January 1, 2022

Study Completion (Actual)

March 1, 2022

Study Registration Dates

First Submitted

December 7, 2025

First Submitted That Met QC Criteria

January 8, 2026

First Posted (Actual)

January 16, 2026

Study Record Updates

Last Update Posted (Actual)

January 21, 2026

Last Update Submitted That Met QC Criteria

January 19, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • IGA_FTK_2021_014
  • 13/2021 (Other Identifier: Faculty of Physical Culture Palacky University Olomouc)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on gait imagery

Subscribe